Introduction: The burden of tuberculosis drug resistance in Eastern Europe: the Moldavian experience

V. Crudu (Chisinau, Republic Of Moldova)

Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis
Session: Multidrug-resistant and extensively drug-resistant tuberculosis
Session type: Oral Presentation
Number: 347
Disease area: Respiratory infections

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Crudu (Chisinau, Republic Of Moldova). Introduction: The burden of tuberculosis drug resistance in Eastern Europe: the Moldavian experience. Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: The burden of tuberculosis drug resistance in Eastern Europe: The Moldavian experience
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

Multidrug-resistant tuberculosis in Eastern Europe: still on the increase?
Source: Eur Respir J 2012; 39: 1290-1291
Year: 2012


Introduction: The need for better diagnostics for tuberculosis in Europe
Source: Annual Congress 2010 - Interferon-gamma releases assays (IGRAs) for the diagnosis of tuberculosis: what is the role?
Year: 2010

Our experience with multiple drug-resistant tuberculosis in Plovdiv Region, Bulgaria – 1999–2004
Source: Eur Respir J 2006; 28: Suppl. 50, 379s
Year: 2006

Control of MDR-/XDR-TB and elimination of TB in Europe: status update
Source: Annual Congress 2012 - Fighting MDR- and XDR-TB in Europe: from programme results to research implementation
Year: 2012


Possibilities of the epidemiological surveillance of tuberculosis in North Caucasus
Source: Eur Respir J 2001; 18: Suppl. 33, 175s
Year: 2001

The shorter multidrug-resistant tuberculosis treatment regimen in Singapore: are patients from South-East Asia eligible?
Source: Eur Respir J, 50 (2) 1700753; 10.1183/13993003.00753-2017
Year: 2017



Is Europe ready to reach tuberculosis elimination? An outbreak report from Southern Italy
Source: Eur Respir J 2015; 46: 274-277
Year: 2015


Rise of tuberculosis in Macedonia, following the Kosovo refugees crisis and the war in the country
Source: Eur Respir J 2005; 26: Suppl. 49, 196s
Year: 2005

Study of drug resistance among untreated new cases of tuberculosis in Oran, Algeria
Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis
Year: 2008


Pseudomonas eradication treatment in Europe: Are there still differences between former East and West?
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019


DOTS strategy impact on the tuberculosis endemic evolution in Bucharest (Romania)
Source: Annual Congress 2006 - Clinical epidemiology of tuberculosis
Year: 2006


Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016


Drug resistant tuberculosis in Odessa, Southern Ukraine: Beijing family strains prevalence and the role of prisons in drug resistant TB transmission
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006

Dynamics of MBT drug resistance in Saratov Region Hospital, Russia
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016

Tuberculosis elimination: theory and practice in Europe
Source: Eur Respir J 2014; 43: 1410-1420
Year: 2014



Success in putting TB epidemic under control, implementing DOTS-strategy in the penitentiary system of Tomsk Oblast, Western Siberia, Russia
Source: Eur Respir J 2001; 18: Suppl. 33, 313s
Year: 2001

TB elimination: theory and practice in Europe
Source: School Course 13
Year: 2013